- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: PRO 140 | PRO-140 | PRO140
Compound class: Antibody
Comment: Leronlimab (PRO140) is a humanized anti-CCR5 (C-C motif chemokine receptor 5) monoclonal antibody [5-6]. It was originally developed by CytoDyn as a novel strategy to manage CCR5-tropic HIV infection .
COVID-19: Leronlimab has been administered to a number of patients with severe COVID-19, to determine its potential to reduce cytokine storm caused by this disease.
|International Nonproprietary Names|
|PRO 140 | PRO-140 | PRO140|
|GtoPdb PubChem SID||405560193|
|Search PubMed clinical trials||leronlimab|
|Search PubMed titles||leronlimab|
|Search PubMed titles/abstracts||leronlimab|